-
IIFL Finance
682.40 704.90(%) -
NSE
2,113.70 2,134.00(%) -
Coforge
2,060.00 2,127.30(%) -
SBI
1,142.00 1,234.80(%) -
Reliance Industries
1,354.00 1,152.30(%) -
Billionbrains
222.40 142.05(%) -
Urban Company
173.90 183.65(%) -
Eternal
365.10 212.55(%) -
Cummins India
3,968.00 3,883.30(%) -
ITC
298.00 410.95(%) -
Bharat Forge
1,683.00 1,328.15(%) -
V2 Retail
122.70 122.70(%) -
Greenlam Industr
231.55 280.60(%) -
ICICI Bank
1,610.00 1,616.70(%) -
Axis Bank
1,356.80 1,150.50(%) -
Polycab India
7,294.50 6,660.50(%) -
Adani Energy Sol
1,460.00 804.70(%) -
Lalithaa Jewel
314.20 240.30(%) -
Bajaj Finance
1,089.55 788.40(%) -
Tata Motors
436.00 308.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Novelix Pharmaceuticals Ltd Trading
- Indian Private
- BSE Code : 33252.0
- ISIN : INE314I01036
-
Today’s Low
61.91 -
Today’s High
67.97
-
Open
63.50 -
Perv Close
64.19 -
52W Low
49.01 -
52W High
92.00
Key Indicators
-
P/E(TTM)
40.12
-
Mar.Cap (₹Cr.)
187.33
-
Div & Yield %
0.00
-
Book Value(₹)
22.95
-
Debt-Equity Ratio
2.51
-
AGM Date
18-Nov-2026
-
EPS
1.64
-
P/E Ratio
40.12
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
187.33
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
28.47
-
BV (₹)
23.00
-
Sales( ₹ in Cr.)
132.31
-
NP (in Cr.)
2.56
-
NP Var(%)
2926.0
-
Div%
0.0
-
CPS (₹)
0.90
-
EPS (₹)
0.90
-
Traded Value (₹ in Lakhs)
187.33
-
52 Week High
92.00
-
52 Week Low
49.01
-
Price BSE
66.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
187.33
-
P/C Ratio
70.70
-
P/E Ratio
73.50
-
Price Vs.BV
0.90
-
04-Nov-2026( 07:31)
Corporate News - Novel... - <p>Novelix Pharmaceuticals Lim...
-
06-Oct-2026( 03:25)
Corporate News - Novel... - <p>Novelix Pharmaceuticals Lim...
-
02-Oct-2026( 07:57)
Corporate News - Novel... - <p>Novelix Pharmaceuticals Lim...
-
30-Sep-2026( 04:42)
Corporate News - Novel... - <p>Novelix Pharmaceuticals Lim...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 132.31 | 30.72 | 4.22 | 1.92 | 1.14 | 1.31 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 132.31 | 30.72 | 4.22 | 1.92 | 1.14 | 1.31 |
| Other Income | 0.03 | 0.02 | 0.31 | 0.00 | 0.25 | 0.00 |
| Stock Adjustments | 13.59 | -0.35 | 0.37 | 0.29 | 0.28 | -0.14 |
| Total Income | 145.93 | 30.39 | 4.90 | 2.21 | 1.67 | 1.17 |
| EXPENDITURE : | ||||||
| Raw Materials | 140.30 | 29.22 | 4.21 | 1.64 | 1.09 | 0.88 |
| Power and Fuel Cost | 0.07 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Employee Cost | 0.71 | 0.07 | 0.13 | 0.16 | 0.14 | 0.15 |
| Other Manufacturing Expenses | 0.15 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 |
| Selling and Administration Expenses | 1.12 | 0.56 | 0.35 | 0.36 | 0.38 | 0.31 |
| Miscellaneous Expenses | 0.01 | 0.32 | 0.14 | 0.01 | 1.53 | 2.98 |
| Employee Benefit Expenses | 0.71 | 0.07 | 0.13 | 0.16 | 0.14 | 0.15 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 142.35 | 30.22 | 4.84 | 2.21 | 3.17 | 4.36 |
| Operating Profit | 3.58 | 0.16 | 0.06 | 0.00 | -1.49 | -3.19 |
| Interest | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.51 | 0.16 | 0.06 | 0.00 | -1.49 | -3.19 |
| Depreciation | 0.10 | 0.04 | 0.04 | 0.06 | 0.07 | 0.08 |
| Profit Before Tax | 3.41 | 0.12 | 0.02 | -0.06 | -1.56 | -3.27 |
| Current Tax | 0.83 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.02 | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 |
| Reported Net Profit | 2.56 | 0.08 | 0.01 | -0.06 | -1.56 | -3.27 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| Adjusted Net Profit | 2.56 | 0.08 | 0.01 | -0.06 | -1.54 | -3.27 |
| Adjustment below Net Profit | 0.00 | 0.00 | -0.01 | 0.01 | 0.00 | 0.00 |
| P & L Balance brought forward | -1.88 | -1.96 | -1.96 | -2.37 | -0.81 | 2.53 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.07 |
| P & L Balance carried down | 0.68 | -1.88 | -1.96 | -2.43 | -2.37 | -0.81 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 1.21 | 0.08 | 0.01 | -0.07 | -1.93 | -4.04 |
| Earnings Per Share(Adj)-Unit Curr | 1.21 | 0.08 | 0.01 | -0.07 | -1.93 | -4.04 |
| Book Value | 22.05 | 17.63 | 9.08 | 8.88 | 8.94 | 10.87 |
| Book Value(Adj)-Unit Curr | 22.05 | 17.63 | 9.08 | 8.88 | 8.94 | 10.87 |
